World News Intel

Ryanair has signed an agreement for 150 Boeing 737-10 jets with options on a further 150 Boeing 737 MAX airplanes, the biggest
order in Ryanair’s history.

Ryanair has deployed a growing fleet of 737-8-200 airplanes to accelerate its post-pandemic recovery and meet strong travel demand. The 197-seat 737-8-200 model has helped the airline reduce fuel use and emissions by over 20% compared to older
airplanes.

The new order adds the larger 737-10 variant, which offers Ryanair 228 seats and the best unit economics of any Boeing single-aisle airplane.

“Ryanair is pleased to sign this record aircraft order for up to 300 MAX 10s with our aircraft partner Boeing.

These new, fuel efficient, greener technology aircraft offer 21%
more seats, burn 20% less fuel and are 50% quieter than our
B737-NGs,” said Michael O’Leary, Ryanair’s Group CEO. “We expect half of this order will replace older NGs while the remaining 150 aircraft will facilitate controlled, sustainable growth to just over 300 million guests per annum by 2034.

This order, coupled with our remaining Gamechanger deliveries,
will create 10,000 new jobs for highly paid aviation professionals
over the next decade, and these jobs will be generated across all
of Europe’s main economies where Ryanair is currently the No.1 or
No.2 airline.”

Boeing has said that the new order will be added to its Orders
and Deliveries website once the deal is finalized.

“The Boeing-Ryanair partnership is one of the most productive in commercial aviation history, enabling both companies to succeed and expand affordable travel to hundreds of millions of people,” said Boeing President and CEO Dave Calhoun. “Nearly a quarter century after our companies signed our first direct airplane purchase, this landmark deal will further strengthen our partnership. We are committed to delivering for Ryanair and
helping the airline group achieve its goals.”

Source link

Share.
Leave A Reply

Exit mobile version

Subscribe For Latest Updates

Sign up to best of business news, informed analysis and opinions on what matters to you.
Invalid email address
We promise not to spam you. You can unsubscribe at any time.
Thanks for subscribing!